The Use of Supplemental Hydrocortisone in the Management of Persistent Pulmonary Hypertension of the Newborn

OBJECTIVE: Characterize association between hydrocortisone receipt and hospital outcomes of infants with persistent pulmonary hypertension of the newborn (PPHN). STUDY DESIGN: Cohort study of infants ≥34 weeks with PPHN who received inhaled nitric oxide at <7 days of age (2010–2016). We generated...

Descripción completa

Detalles Bibliográficos
Autores principales: Aleem, Samia, Robbins, Cliff, Murphy, Brianna, Elliott, Stephen, Akinyemi, Christiana, Paredes, Nicholas, Tolia, Veeral N., Zimmerman, Kanecia O., Goldberg, Ronald N., Benjamin, Daniel K., Greenberg, Rachel G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052278/
https://www.ncbi.nlm.nih.gov/pubmed/33589734
http://dx.doi.org/10.1038/s41372-021-00943-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052278/
https://www.ncbi.nlm.nih.gov/pubmed/33589734
http://dx.doi.org/10.1038/s41372-021-00943-9

Ejemplares similares